Psychedelic drugs in the treatment of psychiatric disorders

Keyphrases

• Phase II Trial 100%
• Psilocybin 100%
• Antidepressants 50%
• Depression Treatment 50%
• Escitalopram 50%
• Ketamine 50%
• Serious Adverse Events 50%
• Treatment-resistant Depression 50%
• Cancer Patients 50%
• In Cancer 50%
• 12-month Follow-up 50%
• Control Sets 50%
• Psychedelics 50%
• PTSD Treatment 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Posttraumatic Stress Disorder 100%
• Psilocybin 100%
• Malignant Neoplasm 50%
• Antidepressant 50%
• Adverse Event 50%
• Randomized Controlled Trial 50%
• Escitalopram 50%
• Ketamine 50%
• MDMA 50%
• Psychotomimetic 50%